Subtopic Deep Dive

Carbon Monoxide Signaling in Inflammation
Research Guide

What is Carbon Monoxide Signaling in Inflammation?

Carbon monoxide (CO) signaling in inflammation refers to the gasotransmitter's anti-inflammatory effects mediated by heme oxygenase-1 (HO-1) through guanylate cyclase activation and MAPK pathway inhibition in macrophages.

CO from HO-1 suppresses pro-inflammatory cytokine production and promotes resolution in inflammatory models (Paine et al., 2010; Ryter et al., 2002). Studies demonstrate CO's role in mitigating sepsis and ischemia/reperfusion injury via soluble guanylate cyclase (sGC) signaling (Amersi et al., 1999). Over 680 citations document HO-1/CO's therapeutic potential in inflammation (Paine et al., 2010).

Curated Papers

Key Challenges

Why It Matters

CO signaling reduces inflammation in sepsis models by inhibiting HMGB1 release and macrophage activation (Chen et al., 2022; Paine et al., 2010). In cerebral hemorrhage, HO-1/CO limits secondary brain injury from oxidative stress and inflammation (Aronowski and Zhao, 2011). These pathways support development of CO-releasing molecules (CORMs) for autoimmune diseases and ischemia/reperfusion therapy, with preclinical efficacy in fat Zucker rat livers (Amersi et al., 1999; Ryter et al., 2002).

Key Research Challenges

Translating In Vitro to In Vivo Efficacy

CO's anti-inflammatory effects via sGC are robust in macrophages but diminish in whole-organism models due to delivery and half-life issues (Paine et al., 2010). Systemic vasodilation limits CORM dosing in sepsis trials (Ryter et al., 2002).

Distinguishing Signaling from Toxicity

Low-dose CO signaling inhibits MAPK without cytotoxicity, but dose-response curves vary by cell type and inflammation context (Dawson and Snyder, 1994). Oxidative stress interactions complicate therapeutic windows (Dunn et al., 2015).

Targeting Tissue-Specific Inflammation

HO-1/CO protects liver in ischemia/reperfusion but requires validation in brain hemorrhage and kidney injury models (Amersi et al., 1999; Ratliff et al., 2016). Macrophage-specific signaling needs isoform-selective modulators (Paine et al., 2010).

Essential Papers

Reactive oxygen species and mitochondria: A nexus of cellular homeostasis

Joe Dan Dunn, Luis Álvarez, Xuezhi Zhang et al. · 2015 · Redox Biology · 1.1K citations

Reactive oxygen species (ROS) are integral components of multiple cellular pathways even though excessive or inappropriately localized ROS damage cells. ROS function as anti-microbial effector mole...

Gases as biological messengers: nitric oxide and carbon monoxide in the brain

T. Renee Dawson, SH Snyder · 1994 · Journal of Neuroscience · 1.0K citations

In a remarkably brief period of time, NO and CO have been recognized as putative neurotransmitters. These two novel messenger molecules have greatly expanded the criteria for candidacy of a chemica...

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

Elisabeth Abidemi Balogun, Martha Hoque, Pengfei Gong et al. · 2003 · Biochemical Journal · 1.0K citations

The transcription factor Nrf2, which normally exists in an inactive state as a consequence of binding to a cytoskeleton-associated protein Keap1, can be activated by redox-dependent stimuli. Altera...

Molecular Pathophysiology of Cerebral Hemorrhage

Jaroslaw Aronowski, Xiurong Zhao · 2011 · Stroke · 803 citations

Intracerebral hemorrhage (ICH) is an often fatal type of stroke that kills ≈30 000 people annually in the United States. If the patient survives the ictus, then the resulting hematoma within brain ...

The mechanism of HMGB1 secretion and release

Ruochan Chen, Rui Kang, Daolin Tang · 2022 · Experimental & Molecular Medicine · 717 citations

Abstract High mobility group box 1 (HMGB1) is a nonhistone nuclear protein that has multiple functions according to its subcellular location. In the nucleus, HMGB1 is a DNA chaperone that maintains...

Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential

Ananta Paine, Britta Eiz‐Vesper, Rainer Blasczyk et al. · 2010 · Biochemical Pharmacology · 684 citations

Oxidant Mechanisms in Renal Injury and Disease

Brian B. Ratliff, Wasan Abdulmahdi, Rahul D. Pawar et al. · 2016 · Antioxidants and Redox Signaling · 672 citations

Despite the limited success associated with the application of antioxidants for treatment of kidney injury/disease thus far, preventing the generation and accumulation of ROS and RNS provides an id...

Reading Guide

Foundational Papers

Start with Dawson and Snyder (1994, 1049 citations) for gasotransmitter basics, then Paine et al. (2010, 684 citations) for HO-1 anti-inflammatory mechanisms, and Ryter et al. (2002, 490 citations) for pathway details.

Recent Advances

Chen et al. (2022, 717 citations) on HMGB1 and inflammation; Ratliff et al. (2016, 672 citations) on oxidant mechanisms relevant to CO protection.

Core Methods

sGC activation assays, MAPK phosphorylation Western blots, CORM administration in rodent sepsis/ischemia models, Nrf2-HO-1 induction via curcumin (Balogun et al., 2003; Amersi et al., 1999).

How PapersFlow Helps You Research Carbon Monoxide Signaling in Inflammation

Discover & Search

PapersFlow's Research Agent uses searchPapers with 'CO signaling inflammation HO-1 macrophages' to retrieve Paine et al. (2010) (684 citations), then citationGraph maps forward citations to Chen et al. (2022) on HMGB1, and findSimilarPapers expands to Ryter et al. (2002). exaSearch uncovers obscure CORM studies in sepsis.

Analyze & Verify

Analysis Agent applies readPaperContent to extract MAPK inhibition mechanisms from Paine et al. (2010), then verifyResponse with CoVe cross-checks claims against Ryter et al. (2002). runPythonAnalysis plots dose-response curves from Amersi et al. (1999) data using pandas/matplotlib; GRADE grading scores HO-1 upregulation evidence as high-quality preclinical.

Synthesize & Write

Synthesis Agent detects gaps in tissue-specific CO signaling via contradiction flagging between macrophage (Paine et al., 2010) and liver models (Amersi et al., 1999). Writing Agent uses latexEditText for methods sections, latexSyncCitations integrates 10+ references, latexCompile generates figures, and exportMermaid diagrams HO-1/CO/sGC pathways.

Use Cases

"Extract dose-response data for CO in macrophage inflammation from key papers."

Research Agent → searchPapers('CO HO-1 macrophage inflammation') → Analysis Agent → readPaperContent(Paine 2010) → runPythonAnalysis(pandas curve fitting) → matplotlib plot of IC50 values.

"Write LaTeX review on CO signaling in sepsis with citations."

Synthesis Agent → gap detection → Writing Agent → latexEditText(draft text) → latexSyncCitations(20 papers) → latexCompile(PDF) → exportBibtex.

"Find GitHub code for simulating HO-1/CO signaling networks."

Research Agent → searchPapers('HO-1 CO signaling model') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (SBML models from Ryter-inspired sims).

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(HO-1 CO inflammation, 50+ papers) → citationGraph → GRADE all claims → structured report on therapeutic gaps (Paine et al., 2010). DeepScan analyzes Paine et al. (2010) in 7 steps: readPaperContent → verifyResponse(CoVe vs. Ryter 2002) → runPythonAnalysis(ROS data). Theorizer generates hypotheses on Nrf2-HO-1-CO axis from Balogun et al. (2003) + Dunn et al. (2015).

Try Doxa for Carbon Monoxide Signaling in Inflammation Research

Frequently Asked Questions

What defines CO signaling in inflammation?

CO from HO-1 acts as an anti-inflammatory gasotransmitter by activating sGC and inhibiting MAPK in macrophages (Paine et al., 2010; Ryter et al., 2002).

What are key methods for studying CO in inflammation?

In vivo models use CORMs in sepsis and ischemia/reperfusion; in vitro assays measure cytokine suppression in HO-1-induced macrophages (Amersi et al., 1999; Paine et al., 2010).

What are seminal papers?

Paine et al. (2010, 684 citations) details HO-1 signaling; Ryter et al. (2002, 490 citations) covers pathways; Dawson and Snyder (1994, 1049 citations) establishes gasotransmitter role.

What open problems exist?

Optimizing CORM delivery for tissue-specific inflammation without toxicity; validating brain vs. liver efficacy differences (Aronowski and Zhao, 2011; Amersi et al., 1999).